MK 3207 HCl inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets CGRP.
Molecular Weight
594.1
Molecular Formula
C31H30ClF2N5O3
Targets
CGRP: 0.12 nM
Form
Lyophilized powder
Purity
>98%
Applications
MK 3207 HCl can be used to research and develop therapeutic strategies for certain diseases that involve excessive activation of GPCR-G protein signaling pathways.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
